Pulmonary aspiration : New therapeutic approaches in the experimental model

Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical conditio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesiology (Philadelphia) 2005-09, Vol.103 (3), p.556-566
Hauptverfasser: BECK-SCHIMMER, Beatrice, ROSENBERGER, Dorothea S, SCHIMMER, Ralph C, NEFF, Simona B, JAMNICKI, Marina, SUTER, Dominik, FUHRER, Thomas, SCHWENDENER, Reto, BOOY, Christa, REYES, Livia, PASCH, Thomas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 566
container_issue 3
container_start_page 556
container_title Anesthesiology (Philadelphia)
container_volume 103
creator BECK-SCHIMMER, Beatrice
ROSENBERGER, Dorothea S
SCHIMMER, Ralph C
NEFF, Simona B
JAMNICKI, Marina
SUTER, Dominik
FUHRER, Thomas
SCHWENDENER, Reto
BOOY, Christa
REYES, Livia
PASCH, Thomas
description Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated. Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined. Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P < 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P < 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P < 0.01) and vascular permeability (80%; P < 0.001). These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.
doi_str_mv 10.1097/00000542-200509000-00019
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68525850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68525850</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-b65d86e6e4cc86f60b4750768652807553b056933b19fd726983613787eaea4c3</originalsourceid><addsrcrecordid>eNpFj1tLxDAQhYMo7rr6FyQv-hbNpbn5Jos3XNQHfS5pOmUjvdm0qP_eLFYcGA5n5mM4gxBm9IJRqy_prmTGCU9CbTIkNbN7aMkkN4QxLffRMs0EEZTzBTqK8T1ZLYU5RAumGLfWsCV6fJnqpmvd8I1d7MPgxtC1-Ao_wScetzC4HqYxeOz6fuic30LEod1tMHz1MIQG2tHVuOlKqI_RQeXqCCezrtDb7c3r-p5snu8e1tcb0nNhR1IoWRoFCjLvjaoULTItqVZGpegpoRQFlcoKUTBblZora4RiQhsNDlzmxQqd_95NkT4miGPehOihrl0L3RRzZSSXRtIEns7gVDRQ5n3Kmz7N_95PwNkMuOhdXQ2u9SH-c5pljAklfgA2IGmr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68525850</pqid></control><display><type>article</type><title>Pulmonary aspiration : New therapeutic approaches in the experimental model</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BECK-SCHIMMER, Beatrice ; ROSENBERGER, Dorothea S ; SCHIMMER, Ralph C ; NEFF, Simona B ; JAMNICKI, Marina ; SUTER, Dominik ; FUHRER, Thomas ; SCHWENDENER, Reto ; BOOY, Christa ; REYES, Livia ; PASCH, Thomas</creator><creatorcontrib>BECK-SCHIMMER, Beatrice ; ROSENBERGER, Dorothea S ; SCHIMMER, Ralph C ; NEFF, Simona B ; JAMNICKI, Marina ; SUTER, Dominik ; FUHRER, Thomas ; SCHWENDENER, Reto ; BOOY, Christa ; REYES, Livia ; PASCH, Thomas</creatorcontrib><description>Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated. Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined. Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P &lt; 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P &lt; 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P &lt; 0.01) and vascular permeability (80%; P &lt; 0.001). These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-200509000-00019</identifier><identifier>PMID: 16129981</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - chemistry ; Capillary Permeability ; Chemokine CCL2 - physiology ; Disease Models, Animal ; Inflammation Mediators - physiology ; Macrophages, Alveolar - physiology ; Male ; Medical sciences ; NF-kappa B - antagonists &amp; inhibitors ; Pneumonia, Aspiration - drug therapy ; Pneumonia, Aspiration - etiology ; Pyrrolidines - therapeutic use ; Rats ; Rats, Wistar ; Respiratory Distress Syndrome, Adult - etiology ; Thiocarbamates - therapeutic use ; Tumor Necrosis Factor-alpha - biosynthesis</subject><ispartof>Anesthesiology (Philadelphia), 2005-09, Vol.103 (3), p.556-566</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17141136$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16129981$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BECK-SCHIMMER, Beatrice</creatorcontrib><creatorcontrib>ROSENBERGER, Dorothea S</creatorcontrib><creatorcontrib>SCHIMMER, Ralph C</creatorcontrib><creatorcontrib>NEFF, Simona B</creatorcontrib><creatorcontrib>JAMNICKI, Marina</creatorcontrib><creatorcontrib>SUTER, Dominik</creatorcontrib><creatorcontrib>FUHRER, Thomas</creatorcontrib><creatorcontrib>SCHWENDENER, Reto</creatorcontrib><creatorcontrib>BOOY, Christa</creatorcontrib><creatorcontrib>REYES, Livia</creatorcontrib><creatorcontrib>PASCH, Thomas</creatorcontrib><title>Pulmonary aspiration : New therapeutic approaches in the experimental model</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated. Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined. Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P &lt; 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P &lt; 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P &lt; 0.01) and vascular permeability (80%; P &lt; 0.001). These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.</description><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Capillary Permeability</subject><subject>Chemokine CCL2 - physiology</subject><subject>Disease Models, Animal</subject><subject>Inflammation Mediators - physiology</subject><subject>Macrophages, Alveolar - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>Pneumonia, Aspiration - drug therapy</subject><subject>Pneumonia, Aspiration - etiology</subject><subject>Pyrrolidines - therapeutic use</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Respiratory Distress Syndrome, Adult - etiology</subject><subject>Thiocarbamates - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFj1tLxDAQhYMo7rr6FyQv-hbNpbn5Jos3XNQHfS5pOmUjvdm0qP_eLFYcGA5n5mM4gxBm9IJRqy_prmTGCU9CbTIkNbN7aMkkN4QxLffRMs0EEZTzBTqK8T1ZLYU5RAumGLfWsCV6fJnqpmvd8I1d7MPgxtC1-Ao_wScetzC4HqYxeOz6fuic30LEod1tMHz1MIQG2tHVuOlKqI_RQeXqCCezrtDb7c3r-p5snu8e1tcb0nNhR1IoWRoFCjLvjaoULTItqVZGpegpoRQFlcoKUTBblZora4RiQhsNDlzmxQqd_95NkT4miGPehOihrl0L3RRzZSSXRtIEns7gVDRQ5n3Kmz7N_95PwNkMuOhdXQ2u9SH-c5pljAklfgA2IGmr</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>BECK-SCHIMMER, Beatrice</creator><creator>ROSENBERGER, Dorothea S</creator><creator>SCHIMMER, Ralph C</creator><creator>NEFF, Simona B</creator><creator>JAMNICKI, Marina</creator><creator>SUTER, Dominik</creator><creator>FUHRER, Thomas</creator><creator>SCHWENDENER, Reto</creator><creator>BOOY, Christa</creator><creator>REYES, Livia</creator><creator>PASCH, Thomas</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Pulmonary aspiration : New therapeutic approaches in the experimental model</title><author>BECK-SCHIMMER, Beatrice ; ROSENBERGER, Dorothea S ; SCHIMMER, Ralph C ; NEFF, Simona B ; JAMNICKI, Marina ; SUTER, Dominik ; FUHRER, Thomas ; SCHWENDENER, Reto ; BOOY, Christa ; REYES, Livia ; PASCH, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-b65d86e6e4cc86f60b4750768652807553b056933b19fd726983613787eaea4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Capillary Permeability</topic><topic>Chemokine CCL2 - physiology</topic><topic>Disease Models, Animal</topic><topic>Inflammation Mediators - physiology</topic><topic>Macrophages, Alveolar - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>Pneumonia, Aspiration - drug therapy</topic><topic>Pneumonia, Aspiration - etiology</topic><topic>Pyrrolidines - therapeutic use</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Respiratory Distress Syndrome, Adult - etiology</topic><topic>Thiocarbamates - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BECK-SCHIMMER, Beatrice</creatorcontrib><creatorcontrib>ROSENBERGER, Dorothea S</creatorcontrib><creatorcontrib>SCHIMMER, Ralph C</creatorcontrib><creatorcontrib>NEFF, Simona B</creatorcontrib><creatorcontrib>JAMNICKI, Marina</creatorcontrib><creatorcontrib>SUTER, Dominik</creatorcontrib><creatorcontrib>FUHRER, Thomas</creatorcontrib><creatorcontrib>SCHWENDENER, Reto</creatorcontrib><creatorcontrib>BOOY, Christa</creatorcontrib><creatorcontrib>REYES, Livia</creatorcontrib><creatorcontrib>PASCH, Thomas</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BECK-SCHIMMER, Beatrice</au><au>ROSENBERGER, Dorothea S</au><au>SCHIMMER, Ralph C</au><au>NEFF, Simona B</au><au>JAMNICKI, Marina</au><au>SUTER, Dominik</au><au>FUHRER, Thomas</au><au>SCHWENDENER, Reto</au><au>BOOY, Christa</au><au>REYES, Livia</au><au>PASCH, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary aspiration : New therapeutic approaches in the experimental model</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>103</volume><issue>3</issue><spage>556</spage><epage>566</epage><pages>556-566</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Acute lung injury caused by gastric aspiration is a frequent occurrence in unconscious patients. Acute respiratory distress syndrome in association with gastric aspiration carries a mortality of up to 30% and accounts for up to 20% of deaths associated with anesthesia. Although the clinical condition is well known, knowledge about the exact inflammatory mechanisms is still incomplete. This study was performed to define the role of alveolar macrophages in this inflammatory response. In addition, potentially modifying effects of intratracheally applied nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate were investigated. Rat alveolar macrophages were depleted by intratracheal administration of clodronate liposomes, and lung injury was evaluated 6 h after instillation of 0.1N hydrochloric acid. In a second set of experiments, pyrrolidine dithiocarbamate was intratracheally instilled 3 h after hydrochloric acid application, and injury parameters were determined. Depletion of alveolar macrophages resulted in decreased production of inflammatory mediators in acid aspiration (23-80% reduction of messenger RNA or protein of inflammatory mediators; P &lt; 0.05) and consequently also in diminished neutrophil recruitment (36% fewer neutrophils; P &lt; 0.01). Treatment with pyrrolidine dithiocarbamate was highly effective in decreasing neutrophil recruitment (66%; P &lt; 0.01) and vascular permeability (80%; P &lt; 0.001). These data suggest that alveolar macrophages play an essential role in the inflammatory response of acid-induced lung injury. For the first time, attenuation of acid-induced lung injury with an inhibitor, applied after the onset of injury, is shown.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>16129981</pmid><doi>10.1097/00000542-200509000-00019</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-3022
ispartof Anesthesiology (Philadelphia), 2005-09, Vol.103 (3), p.556-566
issn 0003-3022
1528-1175
language eng
recordid cdi_proquest_miscellaneous_68525850
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Bronchoalveolar Lavage Fluid - chemistry
Capillary Permeability
Chemokine CCL2 - physiology
Disease Models, Animal
Inflammation Mediators - physiology
Macrophages, Alveolar - physiology
Male
Medical sciences
NF-kappa B - antagonists & inhibitors
Pneumonia, Aspiration - drug therapy
Pneumonia, Aspiration - etiology
Pyrrolidines - therapeutic use
Rats
Rats, Wistar
Respiratory Distress Syndrome, Adult - etiology
Thiocarbamates - therapeutic use
Tumor Necrosis Factor-alpha - biosynthesis
title Pulmonary aspiration : New therapeutic approaches in the experimental model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A11%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20aspiration%20:%20New%20therapeutic%20approaches%20in%20the%20experimental%20model&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=BECK-SCHIMMER,%20Beatrice&rft.date=2005-09-01&rft.volume=103&rft.issue=3&rft.spage=556&rft.epage=566&rft.pages=556-566&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-200509000-00019&rft_dat=%3Cproquest_pubme%3E68525850%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68525850&rft_id=info:pmid/16129981&rfr_iscdi=true